Riad SHERIF’s Post

🚀🔬Exciting developments at California-based Pulse Biosciences!🚀🔬 Pulse Biosciences, Inc., a key player in the MedTech industry, has recently appointed a new CEO. This strategic move is aimed at driving innovation, fostering growth, and shaping the future trajectory of the company in the dynamic healthcare landscape. The company's innovative technology, delivering nanosecond-duration pulses of electrical energy, shows promise in improving atrial fibrillation (AFib) treatments by enabling faster ablations through thicker tissue with potential safety advantages over existing surgical thermal technologies. Recently receiving 510(k) clearance for its Cellfx electrode system in March, Pulse is strategically positioning itself to tap into the surgical AFib market and larger catheter opportunities. The company's leadership team has been restructured to drive forward this plan, with a new CEO, Burke Barrett, taking the reins from Kevin Danahy, who now leads the pilot launch of the Cellfx percutaneous electrode system. Read more here: https://lnkd.in/eDp7Agha #PulseBiosciences #MedTechInnovation #AtrialFibrillation #HealthcareTechnology 🚀🔬

🔬 Exciting News in Biomedical Innovation! 🚀 We proudly announce the successful patent grant for our groundbreaking invention titled "ANGIOGENIN AS A DIAGNOSTIC OR PROGNOSTIC BIOMARKER AND DRUG TARGET IN AGE-RELATED MACULAR DEGENERATION"! This breakthrough work identifies angiogenin as a pivotal biomarker with significant diagnostic and prognostic potential in Age-Related Macular Degeneration (AMD) and establishes it as a promising drug target, opening doors to novel therapeutic interventions. Kudos to our dedicated team whose unwavering commitment to advancing healthcare has led to this remarkable achievement. This patent marks a significant step in redefining the landscape of AMD diagnostics and treatment, underscoring our organization's commitment to making a positive impact on global health. Stay tuned for further updates on our journey towards transforming lives through biomedical innovation! #BiomedicalInnovation #AMD #HealthcareBreakthrough #MedicalResearch #Innovation #PatentGranted #ScientificAdvancement #MedicalScience 🌐👩🔬👨🔬

📍IDG is thrilled to be on the road again in Geneva and Milan on February 21st & 22nd with a European Family Office Event series to introduce three companies transforming diagnostics and bioscience. 🌟Keynote John Davies, CEO of Syniad Innovations, will be addressing the insightful expedition into the heart of healthcare investing: “Meta-Trends in Healthcare Investing,” offering unparalleled insights for those poised to influence and shape the future of humanity through strategic investments. This exclusive presentation will explore three critical facets. Firstly, the intricate challenges of drug discovery, unraveling the complex, two-decade journey of bringing breakthrough medications to market.💊 Secondly, we confront the relentless 300,000-year battle against microbes, underscoring the escalating threats in our ongoing war against pathogens and the imperative for innovative solutions.🦠 Finally, we address the ethical quandary of bifurcation in healthcare advancements—a pressing issue that poses moral dilemmas in the distribution of medical solutions across diverse economic strata.🔬 Meet our renowned presenters: 🩻Matt McGrath, CEO and Andrew Carmichael, COO of Faction Imaging Faction Imaging is developing the next-generation of medical imaging technology. The company has devoted six years to intensive research and development, to form an AI-native imaging platform converging human-centric design, biomedical engineering, and advanced new silicon design, which stands to redefine the landscape of medical diagnostics. 🦠Steven Shallcross, CEO of Theriva Biologics, Inc. Theriva is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. 🧬Brian Firth, CEO of Gemina Labs Gemina Labs is a biosensor and diagnostic company with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. --- Elizabeth Priestman | IDG #familyofficeevent #innovation #medtech #healthcareinnovation #bioscience #drugdiscovery #healthandwellness #immunooncology

🎉 Exciting News! Attention, PE-Investors! 🎉 After some incredibly exciting weeks, I am proud to announce a strategic cooperation with Transgenion. Transgenion, a spin-off of the Medical University of Vienna, is a unique research and development company, founded by Prof. Dr. Rolf Ziesche. By integrating medical, biological, and analytical excellence, Transgenion develops innovative tools for precision medicine against the most challenging chronic inflammatory diseases (CIDs) of advanced age, Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Fibrosis. Whether it's refining internal processes, enhancing external communication strategies, or optimizing SOPs, my team and I are committed to providing Transgenion with comprehensive support. We look forward to playing an important role in their journey towards groundbreaking advancements in precision medicine. Unique Investment Opportunity: After three decades of extensive clinical and molecular research, backed by the EU Research & Innovation funding program „Horizon Europe“ with € 19.5 Mio. and in collaboration with esteemed institutions globally, Transgenion is now approaching another round of financing. This funding will ensure the successful implementation of the CORE Programs. Starting with the CORE Programs, Transgenion is realizing the first useful diagnosis and causal treatment for CID. The completion of Phase 2 marks the equivalent pharmaceutical development value at € 450 Mio. The future of medicine is individual. The term coined for this is Personalized Medicine. A completely new world is just around the corner and you have a unique opportunity to be a part of it. The company's ongoing digitization effort is in progress. I'll be giving regular updates on its progress in the coming weeks. For more detailed information and the pitch deck, feel free to get in touch! #medicine #VC #privateEquity

A new chapter begins!!

🌉 From San Francisco, JP Morgan Healthcare Conference Day 2 Highlights in Genomics and Diagnostics 🧬 1️⃣ Thermo Fisher Scientific: CEO Marc Casper spotlighted the $3.1 billion acquisition of Olink and growth projections for 2024, along with their high-demand Orbitrap Astral mass spectrometer. 2️⃣ Illumina: CEO Jacob Thaysen discussed the future of Grail and the widespread adoption of the NovaSeq X system, with a shift in market focus from sequencing costs to end-to-end workflow efficiency. 3️⃣ Oxford Nanopore Technologies: CEO Gordon Sanghera emphasized their leap towards clinical applications by 2026, fueled by improved Q20+ sequencing accuracy. 4️⃣ Natera: CEO Steve Chapman outlined their financial growth, driven by the Signatera test and improvements in test reimbursements and billing operations. 5️⃣ Agilent Technologies: CEO Mike McMullen projected a recovery year in 2024, with a focus on cancer testing and therapy development. #JPMHC24 #Genomics #Diagnostics #HealthcareInnovation #Biotech

#Interventional_Oncology Market is estimated to grow at a high CAGR >> https://lnkd.in/dDwvbC9C The #Interventional #Oncology Market 2023 research #report gives emerging industry #data, global #segments and regional outlook. This report covers up all details such as #size, share, #value, #growth, restraints, and #opportunities for the year 2023 to 2032. The report generated using various #analysis tools like porter’s five forces #model, #market #attractiveness and value chain. Boston Scientific, C. R. Bard GmbH., Medtronic Cook Medical Merit Medical Systems, Inc., Profound Medical Inc. AngioDynamics, BTG plc, Terumo Medical Corporation, HealthTronics, Inc., EDAP TMS NeuWave Medical, Inc., Sirtex Medical Limited, TROD MEDICAL, Teleflex, Sanarus Technologies IMBiotechnologies Ltd., MedWaves, IceCure Medical #interventionaloncology #healthcareindustry #medicalscience #treatment #diagnosis #researchreport

Imagine a world where your own cells could heal your muscles. Sounds like science fiction? But it's not. Scientists are making this a reality. Deana Mohr-Haralampieva Mohr, CEO of MUVON Therapeutics AG, is leading this revolution. Her team has developed a groundbreaking therapy for stress urinary incontinence. It's minimally invasive and uses the patient's cells. This could change millions of lives. Diana's journey from PhD research to clinical trials was challenging. She faced numerous challenges in bringing this innovation to market. Her story offers valuable insights for scientists and entrepreneurs alike. You'll learn about the potential of autologous muscle tissue regeneration and the hurdles of medical innovation. Curious about the future of regenerative medicine? This episode is a must-listen for anyone interested in cutting-edge biotech. Tune in to explore the frontier of muscle regeneration therapy. #cellculture #processdevelopment #bioprocessing #celltherapymanufacturing #cellandgenetherapy #womenshealth

With the aim of driving investment outcomes, #AusMedtechInvest 2024 features presentations from 8 private and listed Australian medtechs, spanning early to late-stage, seeking partners to further commercialise their technology. Wellumio is great to be part of the #AusMedtechInvest and on the podium today! #AusBioInv #biggestweekinmedtech #AusMedtechInvest2024

The Lifetime Achievement winner has been announced - and what a story! Listen to Dame Carol Robinson, whose pioneering work in mass spectrometry has paved the way for a healthier future, there's a little gem in those few seconds, about how at first, she had doubts about her surprising results. I guess this is normal in science, when things don't behave as expected, the first thing you do is check that everything is in order, make sure that the results are "real". Recognised as our Lifetime Achievement winner, her patented inventions serve as a beacon of hope in the fight against various diseases.    🔗 inventoraward.org     #InventorAward #Healthcare #MedTech #Inventors #BigIdeas #Patents #WomenInSTEM #WomenInTech #WomenInScience